This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
1 JV Higdon & B Frei (2003) Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. Crit Rev Food Sci Nutr 43, 89–143.
3 T Miyazawa (2000) Absorption, metabolism and antioxidative effects of tea catechin in humans. Biofactors 13, 55–59.
7 C Li , MJ Lee , SQ Sheng , (2000) Structural identification of two metabolites of catechins and their kinetics in human urine and blood after tea ingestion. Chem Res Toxicol 13, 177–184.
8 H Lu , XF Meng & CS Yang (2003) Enzymology of methylation of tea catechins and inhibition of catechol-O-methyltransferase by ( − )-epigallocatechin gallate. Drug Metab Dispos 31, 572–579.
9 G Kuhnle , JP Spencer , H Schroeter , (2000) Epicatechin and catechin are O-methylated and glucuronidated in the small intestine. Biochem Biophys Res Commun 277, 507–512.
10 WY Feng (2006) Metabolism of green tea catechins: an overview. Curr Drug Metab 7, 755–809.
11 H Lu , XF Meng , C Li , (2003) Glucuronides of tea catechins: enzymology of biosynthesis and biological activities. Drug Metab Dispos 31, 452–461.
12 JD Lambert , JE Rice , J Hong , (2005) Synthesis and biological activity of the tea catechin metabolites, M4 and M6 and their methoxy-derivatives. Bioorg Med Chem Lett 15, 873–876.
13 F Nanjo , M Mori , K Goto , (1999) Radical scavenging activity of tea catechins and their related compounds. Biosci Biotechnol Biochem 63, 1621–1623.
15 MI Cybulsky & MA Gimbrone Jr (1991) Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 251, 788–791.
16 LE Rohde , RT Lee , J Rivero , (1998) Circulating cell adhesion molecules are correlated with ultrasound-based assessment of carotid atherosclerosis. Arterioscler Thromb Vasc Biol 18, 1765–1770.
17 ZM Dong , SM Chapman , AA Brown , (1998) The combined role of P- and E-selectins in atherosclerosis. J Clin Invest 102, 145–152.
18 RG Collins , R Velji , NV Guevara , (2000) P-selectin or intercellular adhesion molecule (ICAM)-1 deficiency substantially protects against atherosclerosis in apolipoprotein E-deficient mice. J Exp Med 191, 189–194.
19 V Schachinger , MB Britten & AM Zeiher (2000) Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 101, 1899–1906.
20 TJ Anderson , A Uehata , MD Gerhard , (1995) Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 26, 1235–1241.
21 T Heitzer , T Schlinzig , K Krohn , (2001) Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 104, 2673–2678.
22 JPJ Halcox , WH Schenke , G Zalos , (2002) Prognostic value of coronary vascular endothelial dysfunction. Circulation 106, 653–658.
23 U Landmesser , B Hornig & H Drexler (2004) Endothelial function – a critical determinant in atherosclerosis? Circulation 109, 27–33.
24 NN Chan , HM Colhoun & P Vallance (2001) Cardiovascular risk factors as determinants of endothelium-dependent and endothelium-independent vascular reactivity in the general population. J Am Coll Cardiol 38, 1814–1820.
25 K Imai & K Nakachi (1995) Cross sectional study of effects of drinking green tea on cardiovascular and liver diseases. BMJ 310, 693–696.
26 J Sano , S Inami , K Seimiya , (2004) Effects of green tea intake on the development of coronary artery disease. Circ J 68, 665–670.
27 S Sasazuki , H Kodama , K Yoshimasu , (2000) Relation between green tea consumption and the severity of coronary atherosclerosis among Japanese men and women. Ann Epidemiol 10, 401–408.
28 R Hirano , Y Momiyama , R Takahashi , (2002) Comparison of green tea intake in Japanese patients with and without angiographic coronary artery disease. Am J Cardiol 90, 1150–1153.
29 S Kuriyama , T Shimazu , K Ohmori , (2006) Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. JAMA 296, 1255–1265.
30 K Nakachi , S Matsuyama , S Miyake , (2000) Preventive effects of drinking green tea on cancer and cardiovascular disease: epidemiological evidence for multiple targeting prevention. Biofactors 13, 49–54.
31 ME Widlansky , NM Hamburg , E Anter , (2007) Acute EGCG supplementation reverses endothelial dysfunction in patients with coronary artery disease. J Am Coll Nutr 26, 95–102.
32 OH Ryu , J Lee , KW Lee , (2006) Effects of green tea consumption on inflammation, insulin resistance and pulse wave velocity in type 2 diabetes patients. Diabetes Res Clin Pract 71, 356–358.
33 W Kim , MH Jeong , SH Cho , (2006) Effect of green tea consumption on endothelial function and circulating endothelial progenitor cells in chronic smokers. Circ J 70, 1052–1057.
34 FJ Tinahones Madueño , MA Rubio , L Garrido Sánchez , (2007) Green tea reduces LDL oxidability and improves vascular function. Atheroscler Suppl 8, 166.
35 W Lee , WK Min , S Chun , (2005) Long-term effects of green tea ingestion on atherosclerotic biological markers in smokers. Clin Biochem 38, 84–87.
37 N Nagaya , H Yamamoto , M Uematsu , (2004) Green tea reverses endothelial dysfunction in healthy smokers. Heart 90, 1485–1486.
38 N Alexopoulos , C Vlachopoulos , K Aznaouridis , (2008) The acute effect of green tea consumption on endothelial function in healthy individuals. Eur J Cardiovasc Prev Rehabil 15, 300–305.
39 M Antonello , D Montemurro , M Bolognesi , (2007) Prevention of hypertension, cardiovascular damage and endothelial dysfunction with green tea extracts. Am J Hypertens 20, 1321–1328.
40 MA Potenza , FL Marasciulo , M Tarquinio , (2007) EGCG, a green tea polyphenol, improves endothelial function and insulin sensitivity, reduces blood pressure, and protects against myocardial I/R injury in SHR. Am J Physiol Endocrinol Metab 292, E1378–E1387.
41 KY Chyu , SM Babbidge , X Zhao , (2004) Differential effects of green tea-derived catechin on developing versus established atherosclerosis in apolipoprotein E-null mice. Circulation 109, 2448–2453.
43 L Song , MWL Koo , CP Lau , (2008) Effects of green tea on lipids, blood pressure and vasorelaxation in rats with hypercholesterolaemia-induced hypertension. Int J Cardiol 125, Suppl. 1, S64.
44 F Sanae , Y Miyaichi , H Kizu , (2002) Effects of catechins on vascular tone in rat thoracic aorta with endothelium. Life Sci 71, 2553–2562.
45 M Ajay , AU Gilani & MR Mustafa (2003) Effects of flavonoids on vascular smooth muscle of the isolated rat thoracic aorta. Life Sci 74, 603–612.
46 DF Fitzpatrick , SL Hirschfield , T Ricci , (1995) Endothelium-dependent vasorelaxation caused by various plant extracts. J Cardiovasc Pharmacol 26, 90–95.
47 DY Lim , ES Lee , HG Park , (2003) Comparison of green tea extract and epigallocatechin gallate on blood pressure and contractile responses of vascular smooth muscle of rats. Arch Pharm Res 26, 214–223.
48 M Lorenz , S Wessler , E Follmann , (2004) A constituent of green tea, epigallocatechin-3-gallate, activates endothelial nitric oxide synthase by a phosphatidylinositol-3-OH-kinase-, cAMP-dependent protein kinase-, and Akt-dependent pathway and leads to endothelial-dependent vasorelaxation. J Biol Chem 279, 6190–6195.
49 JZ Shen , XF Zheng , EQ Wei , (2003) Green tea catechins evoke a phasic contraction in rat aorta via H2O2-mediated multiple-signalling pathways. Clin Exp Pharmacol Physiol 30, 88–95.
50 E Alvarez , M Campos-Toimil , H Justiniano-Basaran , (2006) Study of the mechanisms involved in the vasorelaxation induced by ( − )-epigallocatechin-3-gallate in rat aorta. Br J Pharmacol 147, 269–280.
51 U Pfeffer , N Ferrari , R Dell'Eva , (2005) Molecular mechanisms of action of angiopreventive anti-oxidants on endothelial cells: microarray gene expression analyses. Mutat Res 591, 198–211.
53 T Schewe , Y Steffen & H Sies (2008) How do dietary flavanols improve vascular function? A position paper. Arch Biochem Biophys 476, 102–106.
54 Y Steffen , C Gruber , T Schewe , (2008) Mono-O-methylated flavanols and other flavonoids as inhibitors of endothelial NADPH oxidase. Arch Biochem Biophys 469, 209–219.
55 M Mizugaki , F Ishizawa , T Yamazaki , (2000) Epigallocatechin gallate increase the prostacyclin production of bovine aortic endothelial cells. Prostaglandins Other Lipid Mediat 62, 157–164.
56 M Yamakuchi , C Bao , M Ferlito , (2008) Epigallocatechin gallate inhibits endothelial exocytosis. Biol Chem 389, 935–941.
57 A Ludwig , M Lorenz , N Grimbo , (2004) The tea flavonoid epigallocatechin-3-gallate reduces cytokine-induced VCAM-1 expression and monocyte adhesion to endothelial cells. Biochem Biophys Res Commun 316, 659–665.
58 RH Boger (2003) Asymmetric dimethylarginine (ADMA) modulates endothelial function – therapeutic implications. Vasc Med 8, 149–151.
60 WJ Tang , CP Hu , MF Chen , (2006) Epigallocatechin gallate preserves endothelial function by reducing the endogenous nitric oxide synthase inhibitor level. Can J Physiol Pharmacol 84, 163–171.
61 L Actis-Goretta , JI Ottaviani & CG Fraga (2006) Inhibition of angiotensin converting enzyme activity by flavanol-rich foods. J Agric Food Chem 54, 229–234.
62 JB Paquay , GR Haenen , G Stender , (2000) Protection against nitric oxide toxicity by tea. J Agric Food Chem 48, 5768–5772.
66 SJ Duffy , JF Keaney Jr, M Holbrook , (2001) Short- and long-term black tea consumption reverses endothelial dysfunction in patients with coronary artery disease. Circulation 104, 151–156.
68 SB Lotito & B Frei (2006) Consumption of flavonoid-rich foods and increased plasma antioxidant capacity in humans: cause, consequence, or epiphenomenon? Free Radic Biol Med 41, 1727–1746.
69 EL Da Silva , M Piskula & J Terao (1998) Enhancement of antioxidative ability of rat plasma by oral administration of ( − )-epicatechin. Free Radic Biol Med 24, 1209–1216.
70 IF Benzie , YT Szeto , JJ Strain , (1999) Consumption of green tea causes rapid increase in plasma antioxidant power in humans. Nutr Cancer 34, 83–87.
71 R Leenen , AJ Roodenburg , LB Tijburg , (2000) A single dose of tea with or without milk increases plasma antioxidant activity in humans. Eur J Clin Nutr 54, 87–92.
72 D Erba , P Riso , A Bordoni , (2005) Effectiveness of moderate green tea consumption on antioxidative status and plasma lipid profile in humans. J Nutr Biochem 16, 144–149.
74 JA Kim , G Formoso , Y Li , (2007) Epigallocatechin gallate, a green tea polyphenol, mediates NO-dependent vasodilation using signaling pathways in vascular endothelium requiring reactive oxygen species and Fyn. J Biol Chem 282, 13736–13745.
75 CC Wu , MC Hsu , CW Hsieh , (2006) Upregulation of heme oxygenase-1 by epigallocatechin-3-gallate via the phosphatidylinositol 3-kinase/Akt and ERK pathways. Life Sci 78, 2889–2897.
78 ME Waltner-Law , XL Wang , BK Law , (2002) Epigallocatechin gallate, a constituent of green tea, represses hepatic glucose production. J Biol Chem 277, 34933–34940.
79 RA Anderson & MM Polansky (2002) Tea enhances insulin activity. J Agric Food Chem 50, 7182–7186.
80 LY Wu , CC Juan , LT Ho , (2004) Effect of green tea supplementation on insulin sensitivity in Sprague–Dawley rats. J Agric Food Chem 52, 643–648.
82 E Ramesh , R Elanchezhian , M Sakthivel , (2008) Epigallocatechin gallate improves serum lipid profile and erythrocyte and cardiac tissue antioxidant parameters in Wistar rats fed an atherogenic diet. Fundam Clin Pharmacol 22, 275–284.
83 TT Yang & MW Koo (1997) Hypocholesterolemic effects of Chinese tea. Pharmacol Res 35, 505–512.
84 S Kono , K Shinchi , K Wakabayashi , (1996) Relation of green tea consumption to serum lipids and lipoproteins in Japanese men. J Epidemiol 6, 128–133.
85 S Tokunaga , IR White , C Frost , (2002) Green tea consumption and serum lipids and lipoproteins in a population of healthy workers in Japan. Ann Epidemiol 12, 157–165.
86 SI Koo & SK Noh (2007) Green tea as inhibitor of the intestinal absorption of lipids: potential mechanism for its lipid-lowering effect. J Nutr Biochem 18, 179–183.
87 TTC Yang & MWL Koo (2000) Chinese green tea lowers cholesterol level through an increase in fecal lipid excretion. Life Sci 66, 411–423.
89 A Bu-Abbas , MN Clifford , C Ioannides , (1995) Stimulation of rat hepatic UDP-glucuronosyl transferase activity following treatment with green tea. Food Chem Toxicol 33, 27–30.
90 S Khokhar & SG Magnusdottir (2002) Total phenol, catechin, and caffeine contents of teas commonly consumed in the United Kingdom. J Agric Food Chem 50, 565–570.
91 RJ Green , AS Murphy , B Schulz , (2007) Common tea formulations modulate in vitro digestive recovery of green tea catechins. Mol Nutr Food Res 51, 1152–1162.
92 HHS Chow , IA Hakim , DR Vining , (2005) Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals. Clin Cancer Res 11, 4627–4633.
93 DD Schramm , M Karim , HR Schrader , (2003) Food effects on the absorption and pharmacokinetics of cocoa flavanols. Life Sci 73, 857–869.
96 S Nagar , JJ Zalatoris & RL Blanchard (2004) Human UGT1A6 pharmacogenetics: identification of a novel SNP, characterization of allele frequencies and functional analysis of recombinant allozymes in human liver tissue and in cultured cells. Pharmacogenetics 14, 487–499.
97 K Sai , Y Saito , M Itoda , (2008) Genetic variations and haplotypes of ABCC2 encoding MRP2 in a Japanese population. Drug Metab Pharmacokinet 23, 139–147.
98 S Gawande , A Kale & S Kotwal (2008) Effect of nutrient mixture and black grapes on the pharmacokinetics of orally administered ( − )epigallocatechin-3-gallate from green tea extract: a human study. Phytother Res 22, 802–808.
100 D Del Rio , AJ Stewart , W Mullen , (2004) HPLC-MSn analysis of phenolic compounds and purine alkaloids in green and black tea. J Agric Food Chem 52, 2807–2815.